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A B S T R A C T
Background: Self-reported psychosis-like experiences (PEs) may be common in patients with mood
disorders, but their clinical correlates are not well known. We investigated their prevalence and
relationships with self-reported symptoms of depression, mania, anxiety, borderline (BPD) and
schizotypal (SPD) personality disorders among psychiatric patients with mood disorders.
Methods: The Community Assessment of Psychic Experiences (CAPE-42), Mood Disorder Questionnaire
(MDQ), McLean Screening Instrument (MSI), The Beck Depressive Inventory (BDI), Overall Anxiety
Severity and Impairment Scale (OASIS) and Schizotypal Personality Questionnaire-Brief form (SPQ-B)
were filled in by patients with mood disorders (n = 282) from specialized care. Correlation coefficients
between total scores and individual items of CAPE-42 and BDI, SPQ-B, MSI and MDQ were estimated.
Hierarchical multivariate regression analysis was conducted to examine factors influencing the
frequency of self-reported PE.
Results: PEs are common in patients withmood disorders. The ‘‘frequency of positive symptoms’’ score of
CAPE-42 correlated strongly with total score of SPQ-B (rho = 0.63; P < 0.001) and moderately with total
scores of BDI, MDQ, OASIS andMSI (rho varied from 0.37 to 0.56; P < 0.001). Individual items of CAPE-42
correlated moderately with specific items of BDI, MDQ, SPQ-B and MSI (rw varied from 0.2 to 0.5;
P < 0.001). Symptoms of anxiety, mania or hypomania and BPD were significant predictors of the
‘‘frequency of positive symptoms’’ score of CAPE-42.
Conclusions: Several, state- and trait-related factors may underlie self-reported PEs among mood
disorder patients. These include cognitive-perceptual distortions of SPD; distrustfulness, identity
disturbance, dissociative and affective symptoms of BPD; and cognitive biases related to depressive or
manic symptoms.
C 2016 Elsevier Masson SAS. All rights reserved.1. Introduction
Self-reported psychosis-like experiences (PEs) resemble posi-
tive psychotic symptoms and are experienced also by individuals
without psychotic illness [1,2]. Numerous epidemiological studies
have indicated that self-reported PEs are common in both the
general population [3–6] and patients with different mental* Corresponding author. Department of Psychiatry, P.O. Box 22 (Va¨lska¨rinkatu
12 A), 00014 Helsinki, Finland. Tel.: +358 9 4711; fax: +358 9 47163735.
E-mail address: erkki.isometsa@hus.fi (E. Isometsa¨).
http://dx.doi.org/10.1016/j.eurpsy.2016.07.005
0924-9338/C 2016 Elsevier Masson SAS. All rights reserved.disorders [7–10]. Individuals with depression and anxiety are
known to more likely report PEs than healthy individuals
[11,12]. Moreover, some studies have indicated that the severity
of mental disorder correlates with frequency and persistency of
self-reported PEs [13,14]. PEs have been associated with psycho-
logical distress [15,16] and higher risk for suicidal thoughts and
behaviour [17,18].
Many studies indicate that self-reported subthreshold PEs are
more prevalent than symptoms exceeding psychotic threshold
[3,19,20]. The noticeable overlap of psychotic and mood disorders
in genetic [21,22], neurobiological [23,24] and environmental risk
factors [25] reflects a phenomenological overlap of psychotic and
I. Baryshnikov et al. / European Psychiatry 51 (2018) 90–97 91mood disorders on both clinical and subclinical levels [26]. Howev-
er, frank psychotic symptoms are also common in mood disorders,
and differences in their prevalence between diagnostic subgroups
have been described. For instance, lifetime psychotic symptoms
were reported by half of patients with bipolar I disorder (BD-1),
twice as common than those with bipolar II disorder (BD-2), the
latter having had psychotic symptoms only when depressed
[27]. For definition of unipolar depression (UD) with psychotic
features, there is a disagreement between the diagnostic classifi-
cations of the International Classification of Diseases 10th Revision
(ICD-10) [28] and the Diagnostic and Statistical Manual of Mental
Disorders Fifth Edition (DSM-5) [29], regarding relationship to
severity of depressive symptoms. The majority of studies indicate
that psychotic symptoms in UD tend to emerge in the more severe
depressive episodes [30–32], but some studies revealed that
depression with psychotic features was not necessarily associated
with severity of depressive symptoms [33–36]. However, psychotic
symptoms in UD were associated with an increased risk for relapse
[33], greater morbidity and residual impairment [37] and worse
outcome of psychotherapy [38].
Both PEs and dissociative symptoms are also among the core
features of some personality disorders, including borderline (BPD)
and schizotypal (SPD) personality disorders. Comorbidity of mood
disorders with personality disorders is high [39,40]. Patients with
UD appear more likely to have cluster A personality disorders and
patients with BD cluster B personality disorders [41]. A higher
occurrence of self-reported PEs and dissociative symptoms in
individuals with personality disorders was associated with higher
distress and worse treatment response [42–44]. Moreover,
patients with self-reported features of BPD or SPD are more likely
to develop a psychotic disorder [45,46].
Detecting of frank psychotic symptoms in patients with mood
disorders is important because of treatment implications [47–
49]. As mentioned before, subthreshold PEs in patients with mood
disorders may have negative prognostic effect on their course and
therefore detecting of PEs is also important, although their
treatment implications are poorly understood. However, their
clinical correlates are not well known.
The Community Assessment of Psychic Experiences (CAPE-42)
has been shown to be a useful self-reported measure of positive,
negative and depressive symptoms with good reliability and
validity [50].We investigated self-reported PEsmeasured by CAPE-
42 in patients with UD and BD to determine the relationships
between self-reported PEs and self-reported symptoms of depres-
sion, mania or hypomania, anxiety, BPD and SPD.We hypothesized
that partial overlap of PEs and mood disorders symptoms can be
observed at the level of self-reported features and the symptoms
are associated with: (a) the severity of mood disorders and, (b)
coexistent features of BPD and SPD. Therefore, we investigated
correlations of the CAPE-42 positive scale with self-reported scales
of anxiety, mood disorders, SPD and BPD on both total scores and
item level and examined factors influencing the prevalence of self-
reported psychotic symptoms in patients with mood disorder.
2. Methods
The Helsinki University Psychiatric Consortium (HUPC) study
design, setting and patient sampling processes are presented in
detail elsewhere [51,52], but are briefly outlined below.
2.1. Setting
The study was conducted in 10 community mental health
centres, three psychiatric inpatient units and one day-hospital
offering specialized secondary public mental health services in the
metropolitan area of Helsinki between 12.1.2011 and20.12.2012. The catchment area (mean population 1139222 in
2012) encompasses the Helsinki metropolitan area, including the
cities of Helsinki, Espoo, Vantaa, Kauniainen, Kerava, and
Kirkkonummi where free-of-charge psychiatric secondary care
services are provided to the residents of the area.
2.2. Sampling
Inclusion criteria were patients’ age of over 18 years and
provision of informed consent. Patients with mental retardation,
neurodegenerative disorders and insufficient Finnish language
skills were excluded. Stratified patient sampling selection was
performed by identifying all patients within a certain day or week
in a unit or by randomly drawing eligible patients from patient
lists. Patients treated for psychotic disorders, neuropsychiatric
disorders, anxiety disorders, eating disorders, BPD, or substance
use disorders as lifetime principal diagnosis were excluded from
this study. Of the 902 eligible patients with mood, neurotic or
personality disorders, 372 refused to participate and 217 were lost
for other reasons. Thirty-one patients with other lifetime diagno-
ses were excluded.
2.3. Clinical diagnoses
The validity of the clinical diagnoses assigned by the attending
physicianswas critically evaluated by the authors by re-examining
all available information from patient records. The validated
clinical diagnoses were based on the ICD-10. Lifetime principal
diagnosis was assigned. We subtyped patients with BD into type I
(BD-1), type II (BD-2) and not otherwise specified (BD-NOS)
according to the DSM-IV.
2.4. Description of patients
Altogether 282 patients participated in the study. Their mean
age was 42.2  13.1 years, and 209 (74.1%) were female. Epidemio-
logical characteristics of patients are presented in Table 1. There were
183 patients with UD (F32–F33) and 99 patients with BD (F31).
Among patients with BD, 36 (36.3%) had BD-1, 55 (55.5%) BD-2 and 8
(8%) BD-NOS. Patients with BD-NOS and BD-2 were allocated to the
same group. Nineteen patients with BD (20%) were hospitalized due
to psychotic mania or psychotic depression (3 patients with BD-2 and
16 with BD-1). Among patients with UD, 14 (8%) had psychotic
depression as a lifetime diagnosis.
2.5. Community Assessment of Psychic Experiences (CAPE-42)
The CAPE-42 is a self-reported questionnaire that measures
lifetime psychotic experiences by using 42 items. The items
measure symptoms in three main domains: Positive Symptoms (20 items);
 Negative Symptoms (14 items);
 Depression Symptoms (8 items).
Each item is rated at a 4-point Likert scale from 1 to 4 for both
symptom frequency and the degree of distress experienced due to
the symptom. Cronbach’s alpha for CAPE-42 total score was
0.854. According to previous studies of the factorial structure of
positive symptoms [53] we grouped items into 5 groups–grandios-
ity, paranoia, magical thinking, delusions and hallucinations.
2.6. McLean Screening Instrument (MSI)
The MSI is a ten-item questionnaire designed according to
DSM-IV diagnostic criteria to screen for BPD [54]. It has been
Table 1
Sociodemographic characteristics of patients with mood disorders (n=282).
BD MDD Total
n % n % n %
Number 99 35 183 65 282 100
Age (mean SD) 43.712.7 41.413.3 42.313
Sex (male) 36 36.3 42 22.9 78 27.7
Marital status
Married 20 20.2 39 21.3 59 21
Cohabiting 17 17.2 29 15.8 46 16.3
Unmarried 32 32.2 75 41 107 38.2
Divorced 29 29.3 35 19.1 64 22.7
Widowed 1 1 3 1.7 4 1.4
Work status
Disability pension due to mental disorder 37 37.4 23 12.5 60 21.2
Unemployed 10 10 18 9.8 28 9.9
Sick leave 22 22.2 64 35 86 30.5
Disability pension for other illness 1 1 8 4.4 9 3.2
Student 7 7.1 24 13.1 31 10.9
Employed 20 20.2 30 16.4 50 17.7
Not employed for other reasons 2 2.2 14 7.7 16 5.7
BD: Bipolar Disorder; MDD: Major Depressive Disorder.
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requires a ‘‘yes/no’’ response. Each positive item indicates the
presence of BPD symptoms. The Kuder-Richardson 20 (KR-20)
coefficient for MSI was 0.747.
2.7. Beck Depression Inventory (BDI)
BDI is a self-report instrument designed to assess and detect the
severity of current depressive symptoms (during the last week) in
clinical and community settings [56]. It contains 21 descriptive
statements regarding depressive symptoms frequently reported by
individuals diagnosed with depression. Each of the items contains
a 4-point severity-rating scale. Cronbach’s alpha for BDI total score
was 0.919.
2.8. Overall Anxiety Severity and Impairment Scale (OASIS)
OASIS is a brief, 5-item self-report questionnaire to assess
frequency, severity and impairment associated with anxiety
[57]. The questionnaire includes five questions regarding the
frequency and severity of anxiety symptoms as well as anxiety-
related avoidance behaviour and decreased functioning at home/
work/school and in social life. Responses range from zero to four.
Cronbach’s alpha for OASIS in the total sample was 0.80.
2.9. Schizotypal Personality Questionnaire-Brief form (SPQ-B)
The SPQ-B is a 22-item self-report instrument derived from the
74-item SPQ questionnaire designed according to DSM-III-R
diagnostic criteria for SPD [58]. Each positive item indicates the
presence of SPD symptoms. Items were created to measure three
dimensions of SPD: 8 items for cognitive-perceptual, 8 items for
interpersonal and 6 items for disorganization. KR-20 separately
was 0.651 for cognitive-perceptual, 0.807 for interpersonal and
0.737 for disorganized dimension.
2.10. Mood Disorder Questionnaire (MDQ)
The MDQ is a brief self-report instrument for screening lifetime
symptoms or behaviours related to a manic or hypomanic
syndrome [59], and it has been translated into Finnish [60]. In
the correlation analysis only the first question’s responses were
used; Cronbach’s alpha for them was 0.890, indicating excellent
internal consistency.2.11. Statistical analysis
The independent-samples t-test was conducted to compare
differences between two continuous variables. The differences
between three or more continuous variables were explored with
ANOVA-test. For variables that met the assumption of homogenei-
ty Tukey’s honestly significant difference (Tukey’s HSD) was used,
otherwisewe used the Games-Howell test in post hoc analysis. The
correlation analysis was conducted between scales’ total scores,
their factors and items. Spearman’s correlation coefficient was
estimated between continuous variables. The phi-coefficient was
calculated for binary variables and the point-biserial coefficient for
dichotomous and continuous variables. To protect against Type I
error in correlation analyses, Bonferroni corrections were conduc-
ted dividing the original a-value by the number of analyses on the
dependent variable. A correlation from 0.6 to 0.79 was regarded as
‘‘strong’’, from 0.40 to 0.59 as ‘‘moderate’’, from 0.20 to 0.39 as
‘‘weak’’ and less than 0.2 as ‘‘very weak’’ [61]. In hierarchical
multivariate regression (HMR) analysis with dependent variables
total scores of frequency of positive symptoms, the following
predictors were used: age, sex, BDI, MDQ, MSI and OASIS. SPQ-B
was not included in the regression analysis to avoid collinearity
bias. The analyses were performed by using SPSS version 22.0 [62].
3. Results
3.1. Total scores of self-reported scales
Overall, 273 patients (96.8%) withmood disorder have reported
experienced PEs ‘‘sometimes’’, ‘‘often’’ or ‘‘always’’. No differences
were present betweenmeans of ‘‘frequency of positive symptoms’’
of patients with and without psychotic depression (P = 0.4).
Likewise, no differences emerged between means of ‘‘frequency
of positive symptoms’’ of BP patients with a history of psychotic
episodes and those without psychotic episodes (P = 0.12). Diffe-
rences in means of CAPE-42 ‘‘frequency of positive symptoms’’
between patients with BD-1, BD-2 and UD were not detected.
Means of total scores of questionnaires are presented in Table 2.
3.2. Frequencies of positive dimension’s items of CAPE-42
Frequencies of positive dimension’s items and their means are
shown in Table 3. Means of the item ‘‘external control’’ were higher
in patients with BD-1 (P < 0.001).
Table 2
Mean scores of self-report scales (MSI, BDI, SPQ-B, MDQ and OASIS) in patients with mood disorder (n=282).
Scale BD-1
Mean (SD)
n=36
BD-2
Mean (SD)
n=63
UD
Mean (SD)
n=183
Pa
McLean Screening Instrument 5.1 (2.6) 6.4 (2.4) 5.4 (2.7) 0.013b
Beck Depression Inventoryf 17.5 (9.7) 24.8 (11.8) 27.5 (12.4) 0.001c
Schizotypal Personality Questionnaire-Brieff 7.7 (5.2) 10.1 (5.5) 9.6 (5.2) 0.474
Mood Disorder Questionnaireg 10.4 (2.9) 9.9 (3.2) 5 (3.7) 0.0001d
Overall Anxiety Severity and Impairment Scaleh 9.5 (4.9) 11.5 (3.9) 11 (4.8) 0.244
Frequency of positive symptomsi 28.6 (7.8) 29.6 (8.2) 28.2 (6.3) 0.401
Distress of positive symptomsj 13.4 (10.9) 17.3 (14.5) 13 (10) 0.206
Frequency of negative symptomsk 30.7 (8.1) 32.9 (6.3) 34.3 (8.1) 0.050e
Distress of negative symptomsl 29.6 (12.1) 31.4 (8.5) 32.1 (10.6) 0.542
Frequency of depressive symptomsm 18.0 (4.4) 20.0 (4.5) 20.8 (4.8) 0.033e
Distress of depressive symptomsn 18.1 (6.9) 19.6 (5.7) 20.8 (6.6) 0.142
a P by ANOVA.
b The mean MSI is higher in patients with BD-2 than BD1 (P<0.005 in post hoc by Turkey’s HSD).
c The mean of BDI item scores is higher in patients with UD than BD-1 (P<0.05 in post hoc by Turkey’s HSD).
d The mean of MDQ is higher in patients with BD-1 than UD (P<0.005 in Post Hoc by Games-Howell).
e The means are higher in patients with UD than BDI-1 (P<0.005 in post hoc by Games-Howell).
f Data missing for 0.3% of patients.
g Data missing for 0.7% of patients.
h Data missing for 0.7% of patients.
i Data missing for 12.5% of patients.
j Data missing for 27.2% of patients.
k Data missing for 7% of patients.
l Data missing for 21.6% of patients.
m Data missing for 4.5% of patients.
n Data missing for 15.7% of patients.
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Correlations between total scores of all questionnaires are given
in Table 4. The CAPE-42 dimension ‘‘frequency of positive
symptoms’’ correlated strongly with total scores of SPQ-B and
moderately withMSI, OASIS, BDI andMDQ (P < 0.01). The CAPE-42
item group ‘‘paranoia’’ correlated strongly with total scores of
MDQ, OASIS, SPQ-B and MSI (P < 0.001) and moderately with
scores of BDI (P < 0.001). The item group ‘‘grandiosity’’ correlated
moderately with the MDQ score (P < 0.001). The item’ group
‘‘magical thinking’’ correlated moderately with SPQ-B scores
(P < 0.001). ‘‘Delusions’’ correlated moderately with all question-
naires’ scores. The group ‘‘hallucinations’’ correlated moderately
with MSI and SPQ-B scores (P < 0.001).
3.4. Item-by-item correlations of positive dimension items of CAPE-42
with
3.4.1. MSI
Items of MSI ‘‘dissociative symptoms’’, ‘‘identity disturbance’’,
‘‘feeling of emptiness’’, ‘‘distrustfulness’’, ‘‘increased anger’’ and
‘‘mood instability’’ correlated moderately with specific CAPE-42
positive dimension items (rpb varied from0.2 to 0.4; P < 0.001) (see
Supplementary Table 1).
3.4.2. BDI
CAPE-42 items ‘‘being persecuted’’, ‘‘people look at you oddly
because of appearance’’, ‘‘hints about you or things with double
meaning’’ correlated moderately with the majority of BDI items
(P < 0.001). BDI items ‘‘punishment feelings’’, ‘‘irritability’’,
‘‘worthlessness’’ and ‘‘self-criticalness’’ correlated moderately or
weakly with CAPE-42 items (rho varied between 0.2 and 0.5;
P < 0.001) (see Supplementary Table 2).
3.4.3. MDQ
CAPE-42 items ‘‘being special or unusual person’’, ‘‘destined to
be very important’’ and ‘‘being persecuted’’ correlated moderately
or weakly with the majority of MDQ items (rpb varied between
0.2 and 0.3; P < 0.005) (see Supplementary Table 3).3.4.4. OASIS
CAPE-42 items ‘‘hints about you or things with double
meaning’’, ‘‘being persecuted’’, ‘‘conspiracy against you’’ and
‘‘people look at you oddly because of appearance’’, among others,
correlated moderately with all items of OASIS (rho varied from
0.2 to 0.4 P < 0.01) (see Supplementary Table 4).
3.4.5. SPQ-B
The majority of SPQ-B items correlated moderately with items
of CAPE-42 (rpb varied between 0.2 to 0.5; P < 0.01) (see
Supplement Table 5).
3.5. Hierarchical multiple regression predicting the frequency of
positive symptoms
In collinearity diagnostics, the variance inflation factor was not
higher than 2.0 for all predictors. The full model of age, sex, BDI,
MDQ, OASIS and MSI in predicting the frequency of positive
symptoms was statistically significant (R2 = .352, F(4, 240) = 21.7,
P < 0.001; adjusted R2 = 0.336). In themodel 1with predictors Age
and Sex (R2 = .062, F(2, 244) = 8.0, P < 0.001; adjusted R2 = 0.05)
variable Age had a significant weight (b = 0.05). The addition of
OASIS, BDI, MDQ and MSI to the prediction of the frequency of
positive symptoms (Model 2) led to a significant increase in R2 of
0.290 with significant weight for age, OASIS, MSI and MDQ
(b = 0.113; 0.161; 0.326; 0.139, respectively) (Table 5).
4. Discussion
We found self-reported PEs to be prevalent among patients
withmood disorders treated in specialized psychiatric settings.We
demonstrated strong correlations between CAPE-42-measured
lifetime self-reported PEs and features of borderline (BPD) and
schizotypal (SPD) personality disorder, and a moderate correlation
of lifetime self-reported PEs with current self-reported symptoms
of anxiety, depressive symptoms and hypomania or mania.
To our knowledge, this is the first study examining self-
reported PEs and their correlationswith self-reported symptoms of
BPD, SPD, depression, anxiety, mania or hypomania in mood
Table 3
Frequencies of CAPE-42 positive dimension’s items and their means in patients with mood disorders (n=282).
CAPE-42
positive dimension’s items
BD-1
n (%)
n=36
BD-2
n (%)
n=63
UD
n (%)
n=183
Means (SD)
Never Sometimes Often Always Never Sometimes Often Always Never Sometimes Often Always BDI-1 BD-2 UD Pa
Hints about you or things with
double meaning
16 (44) 14 (39) 6 (17) 0 (0) 17 (27) 28 (46) 8 (13) 9 (15) 49 (27) 81 (44) 41 (22) 14 (8) 1.9 (0.9) 2.0 (0.9) 2.1 (0.9) 0.48
Things in magazines written
especially for you
30 (86) 5 (14) 0 (0) 0 (0) 54 (86) 6 (10) 3 (5) 0 (0) 163 (89) 18 (10) 1 (0.5) 1 (0.5) 1.2 (0.5) 1.1 (0.4) 1.1 (0.4) 0.49
Some people are not what they
seem to be
16 (44) 15 (42) 3 (8) 2 (6) 23 (37) 28 (44) 11 (18) 1 (2) 74 (40) 78 (42) 26 (14) 6 (3) 1.8 (0.9) 1.8 (0.7) 1.8 (0.8) 0.99
You are being persecuted in
some way
23 (64) 9 (25) 3 (8) 1 (3) 40 (65) 14 (23) 5 (8) 3 (5) 117 (65) 48 (27) 15 (8) 1 (0.5) 1.6 (0.9) 1.5 (0.8) 1.4 (0.7) 0.50
There is conspiracy against you 22 (61) 11 (31) 1 (3) 2 (6) 34 (54) 22 (35) 3 (5) 4 (6) 98 (53) 63 (34) 20 (11) 2 (2) 1.7 (0.9) 1.5 (0.7) 1.6 (0.7) 0.61
You are destined to be someone
very important
20 (57) 10 (29) 5 (14) 0 (0) 41 (66) 19 (31) 1 (2) 1 (2) 140 (75) 35 (20) 10 (5) 1 (0.5) 1.5 (0.7) 1.4 (0.6) 1.3 (0.6) 0.16
You are very special or unusual
person
8 (22) 16 (44) 10 (28) 2 (6) 14 (22) 30 (48) 15 (24) 4 (6) 68 (37) 65 (35) 35 (19) 16 (9) 2.2 (0.8) 2.1 (0.9) 2.0 (1.0) 0.34
People can communicate
telepathically
24 (69) 6 (17) 2 (16) 3 (9) 33 (52) 21 (33) 6 (10) 3 (5) 108 (58) 64 (34) 12 (6) 3 (2) 1.6 (1.0) 1.6 (0.8) 1.5 (0.7) 0.60
Electrical devices can influence
the way you think
32 (89) 3 (8) 1 (3) 0 (0) 60 (95) 2 (3) 1 (2) 0 (0) 165 (90) 13 (7) 3 (2) 2 (1) 1.1 (0.4) 1.0 (0.3) 1.1 (0.5) 0.62
Believe in the power of
witchcraft, voodoo or the
occult
21 (59) 6 (17) 4 (11) 5 (14) 41 (66) 9 (15) 5 (8) 7 (11) 123 (67) 41 (22) 8 (4) 12 (7) 1.9 (1.1) 1.6 (1.0) 1.5 (0.9) 0.05
People look at you oddly because
of appearance
17 (49) 13 (37) 5 (14) 0 (0) 21 (33) 29 (46) 7 (11) 6 (10) 55 (30) 75 (41) 39 (21) 15 (8) 1.8 (0.8) 1.9 (0.1) 2.1 (0.9) 0.10
Thoughts in your head are being
taken away
30 (83) 6 (17) 0 (0) 0 (0) 55 (87) 6 (10) 2 (3) 0 (0) 166 (90) 15 (8) 2 (1) 2 (1) 1.2 (0.4) 1.1 (0.4) 1.1 (0.5) 0.82
Thoughts in your head are not
your own
26 (72) 7 (19) 3 (8) 0 (0) 40 (64) 17 (27) 4 (6) 2 (3) 135 (73) 39 (21) 11 (6) 1 (1) 1.4 (0.7) 1.5 (0.7) 1.3 (0.6) 0.41
So vivid thoughts that you were
worried other people would
hear them
25 (69) 10 (28) 0 (2) 1 (3) 46 (74) 10 (16) 5 (8) 1 (2) 151 (82) 25 (14) 6 (3) 3 (2) 1.4 (0.7) 1.3 (0.7) 1.2 (0.6) 0.29
Your own thoughts have been
echoed back to you
24 (69) 8 (23) 2 (6) 1 (3) 44 (71) 10 (16) 5 (7) 4 (7) 136 (74) 36 (20) 12 (7) 1 (0.5) 1.5 (0.8) 1.4 (0.8) 1.3 (0.6) 0.25
You are under the control of
some force or power
22 (61) 7 (19) 5 (14) 2 (6) 44 (70) 14 (22) 3 (5) 2 (3) 138 (74) 41 (22) 3 (2) 4 (2) 1.7 (1.0) 1.3 (0.6) 1.3 (0.6) 0.00b
Hear voices when you are alone 34 (77) 8 (18) 2 (5) 0 (0) 40 (74) 11 (20) 2 (4) 1 (2) 143 (77) 38 (209 2 (1) 3 (2) 1.3 (0.5) 1.3 (0.6) 1.2 (0.6) 0.79
Hear voices talking to each other 32 (89) 4 (11) 0 (0) 0 (0) 58 (92) 5 (8) 0 (0) 0 (0) 170 (92) 10 (5) 1 (0.5) 3 (1) 1.1 (0.3) 1.1 (0.3) 1.1 (0.5) 0.90
Double had taken the place of a
family member, friend or
acquaintance
35 (97) 1 (3) 0 (0) 0 (0) 59 (95) 3 (5) 0 (0) 0 (0) 179 (97) 3 (2) 0 (0) 3 (2) 1.1 (0.3) 1.0 (0.1) 1.0 (0.4) 0.76
See objects, people or animals
that other people cannot see
35 (97) 1 (3) 0 (0) 0 (0) 51 (81) 11 (18) 0 (0) 1 (2) 167 (90) 16 (9) 2 (1) 1 (0.5) 1.1 (0.3) 1.2 (0.5) 1.1 (0.4) 0.62
CAPE-42: Community assessment of Psychic Experiences; BD-1: Bipolar disorder type I; BD-2: Bipolar disorder type II; UD: unipolar depression; SD: standard deviation.
a P by ANOVA.
b The mean of item scores is higher in patients with BD-1 (n=36) than BD-2 (n=63) or UD (n=188) (P<0.05 in post hoc by Turkey’s HSD).
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Table 4
Correlations (Spearman’s) between total scores of self-reported scales in patients
with mood disorders (n=282).
Scale CAPE-42 SPQ-B BDI MDQ MSI OASIS
SPQa 0.68* 1.0 0.5* 0.32* 0.62* 0.53*
BDIa 0.67* 0.50* 1.0 0.07 0.40* 0.70*
MDQa 0.33* 0.32* 0.07 1.0 0.41* 0.20*
MSIa 0.61* 0.62* 0.40* 0.41* 1.0* 0.45*
OASISa 0.64* 0.53* 0.70* 0.20* 0.46* 1.0
CAPE-42 fpsa 0.7* 0.63* 0.39* 0.37* 0.56* 0.44*
CAPE-42 npsa 0.8* 0.58* 0.67* 0.1 0.35* 0.63*
CAPE-42 dpsa 0.8* 0.56* 0.80* 0.1 0.49* 0.60*
Paranoiab 0.5* 0.3* 0.6* 0.5* 0.6*
Grandiosityb 0.2* 0 0.4* 0.2* 0.1
Magical thinking 0.3* 0 0.1* 0.2* 0
Delusionsb 0.4* 0.3* 0.3* 0.4* 0.3*
Hallucinationsb 0.4* 0.3* 0.2* 0.4* 0.2*
SPQ-B: Schizotypal Personality Questionnaire-Brief; BDI: Beck Depression Inven-
tory; MDQ: Mood Disorder Questionnaire; MSI: McLean Screening Instrument;
OASIS: Overall Anxiety Severity and Impairment Scale; CAPE-42: Community
Assessment of Psychic Experiences; CAPE-42 fps; the ‘‘frequency of positive
symptoms’’ of CAPE-42; CAPE-42 nps: the ‘‘frequency of negative symptoms’’ of
CAPE-42; CAPE-42 dps: the ‘‘frequency of depressive symptoms’’ of CAPE-42.
* P<0.001.
a aalerted = 0.008.
b aalerted = 0.01.
Table 5
Hierarchical multiple regression predicting the frequency of positive symptoms
from age, sex, BDI, OASIS; MDQ and MSI (n=282).
Model 1 Model 2
B Beeta B Beeta
Constant 35.6 22.0
Age 0.137* 0.250* 0.062* 0.113*
Sex 0.724 0.047 0.781 0.050
BDI 0.06 0.102
OASIS 0.245* 0.161*
MDQ 0.223* 0.139*
MSI 0.852* 0.326*
R2 0.062 0.352
F 8.0** 21.7**
D R2 0.062 0.290
DF 8.0** 26.9**
Model 1 (sex, age); Model 2 (age, sex, BDI, OASIS, MDQ, MSI); MSI: McLean
Screening Instrument; BDI: Beck Depression Inventory; OASIS: Overall Anxiety
Severity and Impairment Scale; MDQ: Mood Disorder Questionnaire.
* P<0.05.
** P<0.005.
I. Baryshnikov et al. / European Psychiatry 51 (2018) 90–97 95disorder patients. A strength of our study was the relatively large
number of mood disorder patients, recruited by using stratified
sampling, from the specialized psychiatric care services of the
capital area of Helsinki. Moreover, extensive data of self-reported
symptoms were collected. However, some limitations are also
present. First, the response rate was only 43%, perhaps because the
survey was conducted in busy routine service units. Nevertheless,
the analysis of representativeness indicated no significant
differences in terms of age or sex between our cohort and the
whole population of patients treated in the years 2011 and
2012. Moreover, the sample did not differ in terms of the
demographics from the screening-based, representative Vantaa
Depression Study (UD) and Jorvi Bipolar Study (BD) cohorts from
the same area [27,67]. Second, the clinical diagnoses were not
verified with structured clinical diagnostic interview instruments.
However, all patients had been diagnosed with mood disorders in
psychiatric services specialized in mood disorders. All diagnostic
information was re-evaluated by the authors. Furthermore, the
focus of this study was on self-reported symptoms, not on the
diagnosis per se. The self-report could be affected by impairments
in patients’ self-reflection and social cognition. We acknowledge
that use of observer-rated scales would have strengthened thestudy. First, there are some differences regarding the time span of
reporting the symptoms in the instruments (for instance, lifetime
psychotic symptoms in CAPE-42, but current symptoms of
depression in BDI), which may be confusing for patients with
serious pathology. Overall, whether the PEs symptoms described in
the CAPE and those in the other scales are concurrent or temporally
distinct remains unknown. It is also important to note, that the
CAPE measures frequency of occurrence of PEs over the lifetime,
not e.g. severity of PEs symptoms during a distinct illness episode.
Fourth, the responses were not controlled by scales of desirability
or infrequency.
The high co-occurrence and noticeable phenomenological
overlap of psychotic and mood disorders on the clinical and
subclinical levels have been widely discussed [18,26,38,63]. In line
with previous research, we noted that the self-reported PEs are
prevalent among patients with mood disorders. Interestingly,
there were no differences between positive symptom frequency
scores of mood disorder patients with or without a history of
psychotic symptoms. Moreover, a significant proportion of
patients with mood disorders tended to report PEs ‘‘sometimes’’
or ‘‘often’’. For example, although only 8% of patients had a
psychotic depression as a lifetime diagnosis, 30% of patients
responded ‘‘often’’ or ‘‘always’’ to the item ‘‘Do you ever feel as if
people seem to drop hints about you or say things with a double
meaning?’’ and 29% to the item ‘‘Do you ever feel that people look
at you oddly because of your appearance?’’. Thus, self-reported PEs
in patients with mood disorders appear to be notably more
prevalent than clinical psychotic symptoms. However, it is not
possible to distinguish PEs and frank psychotic symptoms using a
self-report questionnaire, and therefore some of these patients
may actually have had a psychotic episode.
The item-by-item analysis indicated that some items of BDI
correlated with items of CAPE-42 while others did not. For
instance, such self-reported depression symptoms like ‘‘guilty
feelings’’, ‘‘punishment feelings’’, ‘‘self-criticalness’’, and ‘‘worth-
lessness’’ correlated moderately with such self-reported PEs as
‘‘hints and double meanings’’, ‘‘odd looks’’, ‘‘being persecuted and
some others’’. This is in line with previous studies indicating that
subjects who reported feeling of worthlessness or guilt were more
likely to have psychotic symptoms [35,64]. Moreover, such self-
reported PEs like ‘‘being special’’ and ‘‘destined to be important’’
correlated consistently with the majority of self-reported symp-
toms of mania and hypomania. Thus, items reflecting essential
cognitive distortions associated with depression, mania or
hypomania appear to correlate coherently with mood-congruent
self-reported PE. Consequently, individuals scoring higher on items
reflecting mania-, hypomania- or depression-related cognitive
biases tend to more often report PEs.
Psychosis-like symptoms are also one of the core characteristics
of BPD and SPD [29]. We have previously demonstrated that self-
reported features of SPD and BPD are prevalent and intercorrelated
in patients with mood disorders [65]. In particular, self-reported
dissociative symptoms, distrustfulness and identity disturbance of
BPD correlated moderately with self-reported schizotypal symp-
toms. Convergently, mood disorder patients reporting BPD
features ‘‘dissociative symptoms’’, ‘‘distrustfulness’’ and ‘‘identity
disturbance’’ appear to report PEs more often than mood disorder
patients without BPD features. Furthermore, the majority of items
of SPD correlated moderately or strongly with self-reported PE.
This is probably due to similarities between contents of some items
of ‘‘positive symptoms’’ scale of CAPE-42 and ‘‘cognitive-percep-
tual’’ dimension of SPQ-B. On the other hand, a substantial
phenomenological overlap between symptoms of SPD and
schizophrenia may also underlie high correlations between
CAPE-42 and SPQ-B items. Thus, mood disorder patients reporting
features of SPD may also more often report PEs.
I. Baryshnikov et al. / European Psychiatry 51 (2018) 90–9796We demonstrated that symptoms of anxiety, mania or
hypomania, BPD and SPD independently predict frequency of
PEs. In other words, the more complicated the phenomenology of
mood disorders, the more frequent the PEs. This finding supports
previous studies demonstrating an association of psychotic
symptoms with more severe mental illness [66]. In contrast, after
adjusting for the other factors, current depressive symptoms did
not predict PEs. The DSM-5 does not necessitate high severity for
diagnosing a major depressive episode with psychotic features
[29]. Furthermore, some studies have proposed that psychotic
symptoms in UD reflect individual variation in susceptibility to
psychosis rather than severity of depressive symptoms [36]. How-
ever, it is important to note that our patients were recruited from
psychiatric care units specialized in treatment of mood disorders
and therefore tended to have severe depression, which could affect
the generalizability of findings.
To evaluate findings based on self-report it is important to
consider the form and content of items. The CAPE does not include
definitions regarding duration and intensity for the PEs. Conse-
quently, individuals with mood disorders, who in the past had
experienced psychotic symptoms during an episode of psychotic
depression or psychotic mania, may answer ‘‘sometimes’’ or
‘‘often’’ on the CAPE-42 questions. Our findings are therefore more
a reflection of factors correlating with trait-like tendencies to
psychotic-like symptoms, rather than presence of psychotic
symptoms during a mood episode.
Overall, there is a high prevalence of self-reported PEs in mood
disorder patients. Moreover, even patients without clinical
diagnoses of psychotic (unipolar or bipolar) depression or mania
tend to report PEs. Self-reported features of BPD and SPD,
symptoms of anxiety and cognitive distortions related to depres-
sion andmania or hypomania appear to aggravate reporting of PEs
in patients with mood disorders. An accurate comprehensive
clinical diagnostic interview is needed to distinguish clinically
relevant psychotic symptoms from self-reported PEs in patients
with mood disorders.
5. Conclusions
Self-reported PEs are common in patients with mood disorders.
Multiple factors appear to predict reporting of them: self-reported
cognitive-perceptual distortions of schizotypal personality disor-
der; dissociative symptoms, distrustfulness and identity distur-
bance of borderline personality disorder; and cognitive biases of
depression and mania or hypomania. Comprehensive clinical
interviews are necessary to distinguish PEs associated with these
factors from frank psychotic symptoms. Careful assessment of
features of personality disorders is important in patients with
mood disorders who have PEs.
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